IBRX latest filing
Recent Insider Trading Activity ImmunityBio, Inc. (IBRX) Recent Insider Trading Activity From Our SEC Form 4 Tracker
⚠️ THE SAMPLE BELOW IS DEFERRED BY 24 HOURS ⚠️
Start your 2-week, no-credit-card-required free trial today to receive alerts in seconds, on a minute interval or daily.
| Ticker | Filing Date | Company | Insider | Title | Transaction | Shares | Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| IBRX | 2026-07-06 | ImmunityBio, Inc. | Cohen Cheryl | Director | Sell | 131,210 | $9.50 | $1,246,941.11 | 51.13% | View Filing |
| IBRX | 2026-07-06 | ImmunityBio, Inc. | Selecky Christobel | Director | Sell | 159,478 | $9.02 | $1,439,065.68 | 100.00% | View Filing |
| IBRX | 2026-07-01 | ImmunityBio, Inc. | Selecky Christobel | Director | Sell | 96,722 | $9.01 | $871,215.92 | 100.00% | View Filing |
| IBRX | 2026-06-26 | ImmunityBio, Inc. | Simon Barry J. | Director | Sell | 25,000 | $7.88 | $196,907.50 | 0.88% | View Filing |
Real-time employee trading alerts from SEC Form 4 filings.
Pricing
Free Trial
10 trading days$0
Explore every Premium feature before you pay.
- Full platform access
- 10 trading days
- No credit card required
Standard Monthly
Scheduled$19.99 / month
Scheduled alerts with complete trade context.
- Email and Telegram delivery
- Alert intervals from every sixty minutes to once daily
- Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
- Highlighted cluster transactions and direct SEC filing links
Premium Monthly
Recommended$29.99 / month
Fastest alerts with ticker-level control.
- Everything in Standard
- Instant delivery detection-to-outbound time averages 0.84 seconds
- Alert intervals starting from one minute
- Filter alerts by ticker
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.